These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2948992)

  • 1. Repeated dexamethasone suppression test in depressed patients.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 11(2):165-72. PubMed ID: 2948992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
    Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 17. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A; Holsboer F
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.